B+
Bull case
20%
Probability
Target price
$0.95
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
LFT
Lument Finance TrustFNYSE / Financial Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$0.70
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.40
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-13
Recent news sentiment (30D)
+23.7
Positive
Company
-
Unavailable
Macro
+23.7
Positive
Pulse
-
Unavailable
Weekly research (10D)
-32.0
Negative
Sentiment proxy
0.0
Score
AI commentary
News flow is sparse and primarily focused on the Q2 reporting schedule, dividend continuity, and the NYSE price deficiency. As of August 13, the Q2 results and post-print market reaction were not yet available; analyst target or estimate revisions were also unavailable. Social, options, short-interest, and employee data are absent, so these fields should not be treated as positive evidence.
RankAlpha Sentiment Codex - 2026-08-13
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-14eventQ2 2026 filing and investor call will test dividend coverageMedium impact
The company expects to file its June 30, 2026 Form 10-Q after market close on August 13 and hold its investor call on August 14. The key question is whether distributable earnings improved from Q1's $0.02 per share versus the $0.04 common dividend [#IR-2026-08-10] [#SEC-8K-2026-05-20].
2027-01-24catalystNYSE minimum-price deficiency creates continued overhangHigh impact
LFT disclosed that its average closing price was below $1 over 30 trading days. The six-month cure period ends January 24, 2027, and management is considering alternatives including a possible reverse stock split [#IR-2026-07-30] [#8-K-2026-07-30].
2027-01-24catalystCredit and financing normalization could support reratingHigh impact
A durable recovery would require clearer evidence of asset-quality stabilization, financing compliance, and sustainable dividend coverage. Current evidence does not yet establish that recovery, so this remains a low-probability monitoring scenario [#10-Q-2026-05-15].
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-13 • Updated nightlySource: Internal modelMethodology